Want to join the conversation?
$MYL announced the U.S. launch of Metformin Hydrochloride Extended-release Tablets, generic version of Watson's Fortamet. $MYL received final approval from the U.S. Food and Drug Administration (FDA) for Abbreviated New Drug Application (ANDA) for this product that is indicated to improve glycemic control in adults with type 2 diabetes mellitus.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.